Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study
Klara Miriam Elfström, Karin Sundström, Sonia Andersson, Zurab Bzhalava, Agneta Carlsten Thor, Zohra Gzoul, Daniel Öhman, Helena Lamin, Carina Eklund, Joakim Dillner, Sven Törnberg, Klara Miriam Elfström, Karin Sundström, Sonia Andersson, Zurab Bzhalava, Agneta Carlsten Thor, Zohra Gzoul, Daniel Öhman, Helena Lamin, Carina Eklund, Joakim Dillner, Sven Törnberg
Abstract
High screening participation in the population is essential for optimal prevention of cervical cancer. Offering a high-risk human papillomavirus (HPV) self-test has previously been shown to increase participation. In this randomized health services study, we evaluated four strategies with regard to participation. Women who had not attended organized cervical screening in 10 years were eligible for inclusion. This group comprised 16,437 out of 413,487 resident women ages 33-60 (<4% of the screening target group). Among these 16,437 long-term nonattenders, 8,000 women were randomized to either (i) a HPV self-sampling kit sent directly; (ii) an invitation to order a HPV self-sampling kit using a new open source eHealth web application; (iii) an invitation to call a coordinating midwife with questions and concerns; or (iv) the standard annual renewed invitation letter with prebooked appointment time (routine practice). Overall participation, by arm, was (i) 18.7%; (ii) 10.7%; (iii) 1.9%; and (iv) 1.7%. The relative risk of participation in Arm 1 was 11.0 (95% CI 7.8-15.5), 6.3 (95% CI 4.4-8.9) in Arm 2 and 1.1 (95% CI 0.7-1.7) in Arm 3, compared to Arm 4. High-risk HPV prevalence among women who returned kits in study Arms 1 and 2 was 12.2%. In total, 63 women were directly referred to colposcopy from Arms 1 and 2; of which, 43 (68.3%) attended and 17 had a high-grade cervical lesion (CIN2+) in histology (39.5%). Targeting long-term nonattending women with sending or offering the opportunity to order self-sampling kits further increased the participation in an organized screening program.
Trial registration: ClinicalTrials.gov NCT02750124.
Keywords: HPV; cervical cancer; eHealth; screening; self-sampling.
© 2019 UICC.
References
- Arbyn M, Rebolj M, De Kok IM, et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009;45:2671-8.
- Gustafsson L, Sparen P, Gustafsson M, et al. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer 1995;72:498-505.
- Laskey PW, Meigs JW, Flannery JT. Uterine cervical carcinoma in Connecticut, 1935-1973: evidence for two classes of invasive disease. J Natl Cancer Inst 1976;57:1037-43.
- Nieminen P, Kallio M, Anttila A, et al. Organised vs. spontaneous pap-smear screening for cervical cancer: a case-control study. Int J Cancer 1999;83:55-8.
- Nationellt Kvalitetsregister för Cervixcancerprevention. Förebyggande av livmoderhalscancer i Sverige: Verksamhetsberättelse och Årsrapport 2017 med data till och med 2016. Stockholm, Sweden: Nationellt Kvalitetsregister för Cervixcancerprevention, 2017.
- Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9.
- Arbyn M, Smith SB, Temin S, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 2018;363:k4823.
- Kitchener HC, Gittins M, Rivero-Arias O, et al. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC). Health Technol Assess 2016;20:1-138.
- Lam JU, Rebolj M, Moller Ejegod D, et al. Human papillomavirus self-sampling for screening nonattenders: opt-in pilot implementation with electronic communication platforms. Int J Cancer 2017;140:2212-9.
- Tranberg M, Bech BH, Blaakaer J, et al. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures-a randomized controlled trial. BMC Cancer 2018;18:273.
- Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172-83.
- Hakama M, Malila N, Dillner J. Randomised health services studies. Int J Cancer 2012;131:2898-902.
- Soderlund-Strand A, Dillner J. High-throughput monitoring of human papillomavirus type distribution. Cancer Epidemiol Biomarkers Prev 2013;22:242-50.
- Söderlund-Strand A, Wikström A, Dillner J. Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening. J Clin Virol 2015;64:88-91.
- Airell A, Ottosson L, Bygdeman SM, et al. Chlamydia trachomatis PCR (Cobas Amplicor) in women: endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only. Int J STD AIDS 2000;11:651-8.
- Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomarkers Prev 2015;24:769-72.
- Verdoodt F, Jentschke M, Hillemanns P, et al. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015;51:2375-85.
- Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 2011;104:915-20.
- Forss A, Tishelman C, Widmark C, et al. ‘I got a letter…’ a qualitative study of women's reasoning about attendance in a cervical cancer screening programme in urban Sweden. Psychooncology 2001;10:76-87.
- Blomberg K, Ternestedt BM, Tornberg S, et al. How do women who choose not to participate in population-based cervical cancer screening reason about their decision? Psychooncology 2008;17:561-9.
- Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening, 2nd edn. Luxembourg: Office for Official Publications of the European Communities, 2008.
Source: PubMed